Skip to main content
logo
SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
0.7750
+0.0232 (3.09%)
At close: Mar 4, 2026, 4:00 PM EST
0.7678
-0.0072 (-0.93%)
After-hours: Mar 4, 2026, 4:59 PM EST

SCYNEXIS Revenue

In the year 2025, SCYNEXIS had annual revenue of $20.60M with 449.95% growth. SCYNEXIS had revenue of $17.20M in the quarter ending December 31, 2025, with 1,660.70% growth.

Revenue (ttm)
$19.16M
Revenue Growth
+411.40%
P/S Ratio
11.09
Revenue / Employee
$104,714
Employees
28
Market Cap
32.52M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202520.60M16.86M449.95%
Dec 31, 20243.75M-136.40M-97.33%
Dec 31, 2023140.14M135.05M2,652.72%
Dec 31, 20225.09M-8.07M-61.32%
Dec 31, 202113.16M--
Dec 31, 2020---
Dec 31, 2019121.00K-136.00K-52.92%
Dec 31, 2018257.00K--
Dec 31, 2017257.00K--
Dec 31, 2016257.00K--
Dec 31, 2015257.00K-999.00K-79.54%
Dec 31, 20141.26M-8.31M-86.87%
Dec 31, 20139.57M156.00K1.66%
Dec 31, 20129.41M-3.42M-26.67%
Dec 31, 201112.84M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Rockwell Medical75.58M
InterCure72.16M
Aytu BioPharma62.64M
Cumberland Pharmaceuticals41.28M
Zhengye Biotechnology Holding21.46M
TherapeuticsMD2.80M
BioXcel Therapeutics752.00K
Talphera28.00K
Revenue Rankings

SCYX News

More News